KVUE logo

Kenvue Inc. (KVUE)

$17.33

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on KVUE

Market cap

$33.20B

EPS

0.76

P/E ratio

23.1

Price to sales

2.19

Dividend yield

4.789%

Beta

0.59745

Price on KVUE

Previous close

$17.32

Today's open

$17.40

Day's range

$17.30 - $17.49

52 week range

$14.02 - $25.17

Profile about KVUE

CEO

Kirk Perry

Employees

22000

Headquarters

Summit, NJ

Exchange

New York Stock Exchange

Shares outstanding

1.92B

Issue type

Common Stock

KVUE industries and sectors

Consumer Staples

Consumer Products - Healthcare

News on KVUE

INVE$TOR ALERT: The M&A Class Action Firm Encourages KVUE, FSUN, FFWM, and GIFI Shareholders to Protect their Rights

NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

news source

GlobeNewsWire • a day ago

news preview

Dividend Kings: 3 Ideal Buys In 56 For December

Dividend Kings remain largely overvalued, but six—including MO, UVV, HRL, KVUE, CDUAF, and UBSI—are now fairly priced with yields (from $1k invested) exceeding share prices. Analyst forecasts project net gains of 19.89% to 93.08% for select high-yield Dividend Kings by December 2026, with an average net gain of 34.89%. Only three Dividend Kings—MO, KVUE, UBSI—currently meet both the 'safer' dividend and fair price criteria, supported by positive free cash flow yields.

news source

Seeking Alpha • Dec 11, 2025

news preview

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

S&P 500 high-yield 'safer' dividend stocks offer attractive upside, with twelve currently meeting the dogcatcher ideal of dividends exceeding share prices. Analyst targets forecast 21.14% to 44.05% net gains for top-ten S&P 500 dividend dogs by December 2026, with an average 28.35% gain and lower-than-market volatility. Stocks with negative free cash flow margins—fifteen of the top fifty—are flagged as unsafe for dividend sustainability despite high yields.

news source

Seeking Alpha • Dec 9, 2025

news preview

GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities

The US Equity Income Fund underperformed its benchmark, the Russell 1000 Value Index, net of fees during the third quarter. Enterprise software company, Oracle Corporation, was a top contributor to relative returns during the quarter. Our position in consumer healthcare company, Kenvue Inc., was a top detractor from relative performance during the month.

news source

Seeking Alpha • Dec 10, 2025

news preview

Macquarie Value Fund Q3 2025 Contributors And Detractors

Kenvue Inc. (KVUE), a maker of consumer health products including pain reliever Tylenol, was a notable detractor. Information technology services provider Fidelity National Information Services Inc. (FIS) was a primary detractor in the quarter. Alphabet Inc. (GOOG), parent company of search provider Google and other technology platforms such as Google Cloud, Waymo, and YouTube, was a leading contributor.

news source

Seeking Alpha • Dec 7, 2025

news preview

Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out

Kimberly-Clark is acquiring Kenvue in a $48.7 billion cash-and-stock deal. I believe the deal is likely to close, and that Kenvue stock gives folks a decent way to buy Kimberly-Clark at a discount. There is still a solid deal spread here, and I think Kimberly-Clark is undervalued as well, offering additional upside once the deal closes.

news source

Seeking Alpha • Dec 5, 2025

news preview

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—RPTX, CNBN, KMB, and KVUE

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

news source

GlobeNewsWire • Dec 4, 2025

news preview

American Century Value Fund Q3 2025 Contributors/Detractors And Notable Trades

Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. We initiated a position in this customer relationship management software company because it enjoys a dominant market share and a wide competitive moat. We exited our position in nVent. It rallied on the prospect of increasing data center demand, pushing the stock above what we viewed as its fair value.

news source

Seeking Alpha • Dec 1, 2025

news preview

Best Dividend Aristocrats For December 2025

The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW, and ALB, have posted double-digit gains in 2025, while others lag behind. Dividend growth among Aristocrats averages 5.46% for 2025, with most constituents announcing increases, though growth is slightly below 2024 levels.

news source

Seeking Alpha • Nov 29, 2025

news preview

American Century Mid Cap Value Fund Q3 2025 Contributors/Detractors And Notable Trades

Shares of Teradyne advanced sharply as investors cheered the company's robust earnings and outlook for Teradyne's artificial intelligence compute testing business. Shares of Henry Schein declined as promotional activity to attract new customers in its online channel pressured margins. We exited our position in Centene and reallocated proceeds to other positions that we believed offered more attractive risk/reward opportunities.

news source

Seeking Alpha • Nov 20, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Kenvue Inc.

Open an M1 investment account to buy and sell Kenvue Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in KVUE on M1